, Tracking Stock Market Picks
Enter Symbol:
Rating: PRGO

Perrigo Company (NYSE: PRGO) downgraded to Equal-Weight by Morgan Stanley

Thursday,  Dec 3, 2015  10:25 AM ET by Betsy O'Brien Harrison

Morgan Stanley downgraded Perrigo Company (NYSE: PRGO) to Equal-Weight. Previously Morgan
Stanley downgraded to Perrigo Company (NYSE: PRGO) to Overweight with price target $183 on 12/19/2013, when the stock price was $151.14.

Perrigo Company, is the nations largest manufacturer of store brand over-the-counter (non-prescription) pharmaceutical products and also manufactures store brand nutritional products. Store brand products are sold by national and regional supermarket, drugstore and mass merchandise chains under their own labels and compete with nationally advertised brands. The Company's products include analgesics, cough and cold remedies, antacids, laxatives, feminine hygiene and smoking cessation products, and vitamins, nutritional supplements and nutritional drinks.

Morgan Stanley Investment Research is one of the financial industry's dominant thought leaders in equity and fixed-income investing. Our analysts, economists, and strategists have earned this reputation through timely, in-depth analysis of companies, industries, markets, and the world’s economies. Our teams collaborate to assist Morgan Stanley clients with investment decisions, using cash and derivative instruments across major asset classes and geographies.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy